Research graph

References

References from Sustained response (ORR4) as an on-treatment prognostic marker in mogamulizumab-treated mycosis fungoides and Sézary syndrome: the FIL-MOGA study. Local targets link to admitted publications; unresolved targets remain external evidence.

No reference evidence is available for this admitted work.